Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
- Status
- COMPLETED
- Phase
- PHASE3
Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
- Status
- COMPLETED
- Phase
- PHASE2
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
- Status
- COMPLETED
- Phase
- PHASE2
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE1